Envestnet Asset Management Inc. Sells 619 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Envestnet Asset Management Inc. trimmed its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 382,513 shares of the medical instruments supplier’s stock after selling 619 shares during the period. Envestnet Asset Management Inc. owned approximately 0.19% of DENTSPLY SIRONA worth $9,528,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Wahed Invest LLC increased its stake in DENTSPLY SIRONA by 9.3% in the fourth quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock valued at $128,000 after acquiring an additional 306 shares during the last quarter. Raymond James Trust N.A. lifted its holdings in shares of DENTSPLY SIRONA by 4.9% during the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock worth $241,000 after purchasing an additional 453 shares during the period. LRI Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the period. Diversified Trust Co lifted its holdings in shares of DENTSPLY SIRONA by 3.0% during the second quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock worth $489,000 after purchasing an additional 566 shares during the period. Finally, Envestnet Portfolio Solutions Inc. lifted its holdings in shares of DENTSPLY SIRONA by 6.6% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,748 shares of the medical instruments supplier’s stock worth $357,000 after purchasing an additional 662 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $27.05 on Friday. DENTSPLY SIRONA Inc. has a one year low of $23.58 and a one year high of $37.60. The firm has a market capitalization of $5.48 billion, a PE ratio of -61.48, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00. The company has a 50-day simple moving average of $25.54 and a two-hundred day simple moving average of $27.65. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.51 EPS. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.37%. DENTSPLY SIRONA’s payout ratio is presently -145.45%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Stifel Nicolaus cut their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Barrington Research restated an “outperform” rating and set a $36.00 price target on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Finally, Needham & Company LLC restated a “buy” rating and set a $34.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Moderate Buy” and an average target price of $33.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.